GlassScriptPhysician profile
Kristin Brigger
NPI 1407174881
$14,623.12
in general payments reported to CMS, 2019-2025
38 companies · $831 in 2025
The $831 reported for 2025 was more than what 89% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $8,988 · 2020: $1,837 · 2021: $569 · 2022: $999 · 2023: $772 · 2024: $628 · 2025: $831.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,146 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,145.97 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $10,141.10 | 2019-2020 | |
| Abbvie INC. | $835.97 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Astellas Pharma US INC | $421.72 | 2022-2025 | Veozah, Myrbetriq |
| Hologic Sales and Service, LLC | $341.39 | 2020-2025 | Novasure, Myosure Tissue Removal Device, Aptima |
| Bayer Healthcare Pharmaceuticals INC. | $295.62 | 2020-2025 | |
| Mayne Pharma Commercial LLC | $287.77 | 2021-2025 | |
| Medtronic, INC. | $218.46 | 2021-2025 | Truclear |
| Myovant Sciences INC. | $207.60 | 2021-2022 | |
| Exeltis, USA INC. | $190.14 | 2020-2024 | Slynd |
| Sage Therapeutics, LLC | $185.16 | 2021-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $172.04 | 2023-2025 | Myfembree |
| Coopersurgical, INC. | $129.93 | 2020-2025 | Sos, Paragard T 380a |
| Avion Pharmaceuticals | $120.90 | 2020 | |
| Exact Sciences Corporation | $102.20 | 2023-2025 | Cologuard Collection Kit |
| Millicent US INC | $96.53 | 2024-2025 | Intrarosa, Femring, Femlyv |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Evofem Biosciences, INC. | $89.57 | 2021-2024 | |
| Organon LLC | $71.26 | 2022-2025 | Nexplanon |
| Pfizer INC. | $68.18 | 2020-2025 | |
| Medicem INC. | $67.52 | 2020-2022 | |
| Mylan Pharmaceuticals INC. | $59.71 | 2020-2022 | |
| Davol INC. | $59.45 | 2024 | Arista Ah Flexitip |
| Shield Therapeutics INC | $51.68 | 2022-2025 | |
| Integra Lifesciences Corporation | $48.03 | 2025 | Duraseal Exact Spinal Sealant System, Codman Certas, Codman Hakim |
| Covidien LP | $43.73 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $43.39 | 2023 | Iovera, Exparel |
| Daiichi Sankyo INC. | $39.32 | 2020-2021 | |
| Ethicon US, LLC | $30.43 | 2025 | Stratafix, Ethicon, Dermabond |
| Innovation Technologies INC | $26.71 | 2024 | Irrisept |
| Vertical Pharmaceuticals, LLC | $20.07 | 2020 | |
| Smith+Nephew, INC. | $20.06 | 2023 | Stravix, Grafix Pl |
| Optumhealth Care Solutions, LLC | $19.69 | 2023 | Vivify Health Care Team Portal, Zyno Solutions |
| Supernus Pharmaceuticals, INC. | $19.37 | 2025 | Qelbree |
| Aspira Women'S Health INC | $18.52 | 2025 | Ova1 |
| Lupin INC. | $16.61 | 2020 | |
| Dexcom, INC. | $16.49 | 2025 | Dexcom G6 Transmitter |
| Novo Nordisk INC | $16.04 | 2024 | Wegovy |
| Allergan, INC. | $15.92 | 2020 | |
| Agile Therapeutics, INC. | $14.84 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kristin Brigger listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.